Ovid Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Ovid Therapeutics Inc.‘s stocks are currently a part of 35 hedge funds’ portfolios, which represents 24.98% of the total amount of its stocks outstanding. This makes up a total of 17.59M shares of Ovid Therapeutics Inc.. Compared to the previous quarter, the number fell by -54.38% or -20.96M shares fewer. As for the holding position changes, 31.43% (11) of current hedge fund investors increased the number of shares held, 22.86% (8) of current holders sold a part of the shares held, and 11.43% (4) closed the holdings completely. 3 hedge funds are new holders of Ovid Therapeutics Inc. stock in Q1 2023, it is 8.57% of total holders.
Hedge funds holding Ovid Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 48 |
|---|---|
| Q3 2018 | 49 |
| Q4 2018 | 46 |
| Q1 2019 | 49 |
| Q2 2019 | 33 |
| Q3 2019 | 38 |
| Q4 2019 | 61 |
| Q1 2020 | 56 |
| Q2 2020 | 79 |
| Q3 2020 | 90 |
| Q4 2020 | 78 |
| Q1 2021 | 86 |
| Q2 2021 | 78 |
| Q3 2021 | 70 |
| Q4 2021 | 66 |
| Q1 2022 | 60 |
| Q2 2022 | 54 |
| Q3 2022 | 57 |
| Q4 2022 | 59 |
| Q1 2023 | 35 |
Hedge funds changes in Ovid Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 9 | 20 | 11 | 9 | -1 |
|---|---|---|---|---|---|
| Q3 2018 | 8 | 20 | 10 | 7 | 4 |
| Q4 2018 | 9 | 11 | 16 | 12 | -2 |
| Q1 2019 | 9 | 23 | 6 | 6 | 5 |
| Q2 2019 | 3 | 10 | 14 | 17 | -11 |
| Q3 2019 | 13 | 7 | 12 | 7 | -1 |
| Q4 2019 | 28 | 22 | 5 | 5 | 1 |
| Q1 2020 | 11 | 16 | 20 | 14 | -5 |
| Q2 2020 | 39 | 18 | 17 | 17 | -12 |
| Q3 2020 | 24 | 22 | 28 | 13 | 3 |
| Q4 2020 | 12 | 39 | 14 | 22 | -9 |
| Q1 2021 | 23 | 26 | 22 | 16 | -1 |
| Q2 2021 | 20 | 18 | 30 | 27 | -17 |
| Q3 2021 | 11 | 19 | 26 | 19 | -5 |
| Q4 2021 | 11 | 15 | 21 | 15 | 4 |
| Q1 2022 | 7 | 22 | 17 | 13 | 1 |
| Q2 2022 | 8 | 11 | 24 | 14 | -3 |
| Q3 2022 | 9 | 18 | 18 | 6 | 6 |
| Q4 2022 | 10 | 10 | 21 | 8 | 10 |
| Q1 2023 | 3 | 11 | 8 | 4 | 9 |
Hedge funds changes in Ovid Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 768,000 | 434,000 |
| Q3 2020 | 760,000 | 465,000 |
| Q4 2020 | 205,200 | 703,000 |
| Q1 2021 | 1,254,000 | 4,021,000 |
| Q2 2021 | 1,782,000 | 2,831,000 |
| Q3 2021 | 1,172,000 | 2,086,000 |
| Q4 2021 | 1,197,000 | 0 |
| Q1 2022 | 231,000 | 0 |
| Q2 2022 | 116,000 | 0 |
| Q3 2022 | 52,000 | 0 |
| Q4 2022 | 17,112 | 0 |
| Q1 2023 | 0 | 3,000 |